UK Spring Budget allocates funds to life sciences manufacturing

Chancellor of the Exchequer Jeremy Hunt announced a £360m investment into R&D and manufacturing in the Spring budget. Credit: Sean Aidan Calderbank via Shutterstock. Leading up to the UK Spring Budget announcement this week, Chancellor of the Exchequer Jeremy Hunt declared a £360m ($456.6m) investment into UK research and development (R&D) and manufacturing. The government […]
Microplastics in placentas: how serious is the problem?

The presence of microplastics in the placenta could have serious implications for fertility. Credit: SP-Photo / Shutterstock. Newly published research into the presence of microplastics in human placentas has found them in all 62 samples tested, raising questions about the potential impact on fertility and health. The full impact of microplastics on human (and animal) […]
MediView AR system demonstrates accuracy through clinical trial

The MediView XR90 system is a US Food and Drug Administration (FDA) 510(k) cleared device currently in clinical use. Credit: Shutterstock / Zapp2Photo The Cleveland-based augmented reality (AR) firm, MediView XR, has announced the results of a trial studying its XR90 surgical visualization and navigation system, finding it accurate enough to carry out procedures with […]
Analog Devices’s Sensinel CPM System receives 510(k) clearance

The Sensinel CPM System is the inaugural product under the new Sensinel by Analog Devices brand. Credit: PRNewswire/ Analog Devices, Inc. Analog Devices (ADI) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Sensinel cardiopulmonary management (CPM) system. The Sensinel CPM System is a non-invasive, remote management and wearable device. […]
SEKISUI’s combo flu and Covid-19 test obtains EUA

The OSOM Flu SARS Combo Test Kit. Credit: PRNewswire/SEKISUI Diagnostics. SEKISUI Diagnostics has received Emergency Use Authorization (EUA) for its OSOM Flu SARS-CoV-2 Combo Test. The test is designed for the simultaneous qualitative detection and differentiation of influenzas A and B nucleoprotein antigens, as well as SARS-CoV-2 nucleocapsid antigen. Intended for professional use and self-testing […]
Dexcom’s glucose biosensor secures US FDA approval

The Stelo glucose biosensor will be made available in the US. Credit: Business Wire/ DexCom. DexCom has received the US Food and Drug Administration (FDA) approval for Stelo by Dexcom glucose biosensor as an over-the-counter product. Said to be the first glucose biosensor in the US cleared for use without a prescription, the Stelo continuous […]
Haemonetics to acquire Attune Medical for $160m

The acquisition brings Attune Medical’s proactive esophageal cooling device into Haemonetics’ portfolio. Credit: Kateryna Kon/ Shutterstock.com. Haemonetics has signed an agreement for the acquisition of Attune Medical, which manufactures the ensoETM proactive oesophagal cooling device, for a $160m upfront payment. The transaction value also includes additional sales-based contingent consideration. This acquisition brings the US Food […]
Method for Determining Tissue Boundaries in Ultrasound Images
According to GlobalData’s company profile on Koninklijke Philips, Treatment progress monitoring was a key innovation area identified from patents. Koninklijke Philips‘s grant share as of January 2024 was 57%. Grant share is based on the ratio of number of grants to total number of patents. Method for determining tissue boundaries in ultrasound images Source: United […]
Patent Filed by Paragon 28 Inc for Correcting Bone Deformities in Lower Extremity
According to GlobalData’s company profile on Paragon 28, Cardiothoracic surgery instruments was a key innovation area identified from patents. Paragon 28‘s grant share as of January 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents. Surgical method for correcting bone deformities in lower extremity Source: […]
Veracyte Inc Patent for Homologous Recombination Deficiency Prostate Cancer
According to GlobalData’s company profile on Veracyte, ML-based biomarker screening was a key innovation area identified from patents. Veracyte‘s grant share as of January 2024 was 26%. Grant share is based on the ratio of number of grants to total number of patents. Diagnosis and treatment of homologous recombination deficiency prostate cancer Source: United States […]